Management of hepatitis C virus infection recurrence after liver transplantation: an overview

Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani, P Burra, S. Fagiuoli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

Hepatitis C virus (HCV) infection is the major indication for liver transplantation worldwide. Its recurrence is virtually universal. Once reinfection is established, progression to cirrhosis occurs in 25%-30% of recipients within 5 years. Several studies have attempted to identify the ideal antiviral treatment for liver transplant recipients. At present, the management of recurrent HCV infection in liver transplant recipients is based on widely accepted indications, which represent a reliable guide to identify the "ideal" candidate for therapy, when therapy should be started, and what is to be expected in terms of side effects and response to treatment.
Lingua originaleEnglish
pagine (da-a)291-295
Numero di pagine5
RivistaTransplantation Proceedings
Volume43
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Hepatitis C
  • Humans
  • Liver Transplantation
  • Recurrence

Fingerprint Entra nei temi di ricerca di 'Management of hepatitis C virus infection recurrence after liver transplantation: an overview'. Insieme formano una fingerprint unica.

Cita questo